Original title: Modulation of spatial learning and memory by cannabinoid-estrogen interaction in an AD-like cognitive impairment: The role of cannabinoid receptors and BDNF protein
Mohammad Ali Mirshekar, Farzaneh Nadi, Hamed Fanaei, Mohadeseh Chahkandi · September 2026
Alzheimer's disease damages memory, and women face a higher risk, possibly because estrogen levels drop after menopause. Scientists wanted to see if cannabis compounds could help treat this memory loss and whether combining them with estrogen works even better. They studied female rats whose ovaries had been removed to mimic menopause, then gave them amyloid-beta proteins in the brain to create Alzheimer's-like memory problems. The rats received a daily marijuana extract containing THC, either on its own or alongside estradiol, an estrogen hormone, for 28 days. The marijuana extract works by interacting with brain systems, altering brain-derived neurotrophic factor, a protein that supports brain cells, and changing CB1 cannabinoid receptors. The researchers found that the marijuana extract helped the rats learn and remember spatial tasks better. Surprisingly, adding estradiol did not create an extra boost, showing that cannabinoid and estrogen pathways interact in complicated ways.
Imagine you are trying to fix a leaky faucet. You try a standard wrench, and it works a bit, but not perfectly. Then you add a special lubricant, expecting it to help more, but it doesn't make any difference. In this paper, the leaky faucet is the memory problems in Alzheimer's-like rats, the wrench is the marijuana extract, and the lubricant is estrogen. The researchers found that the wrench helped, but adding the lubricant didn't improve things further, suggesting the two tools interact in a complicated way.
This research suggests that cannabis-based compounds might help with memory loss in Alzheimer's, especially in women after menopause when estrogen levels drop. However, the finding that adding estrogen didn't enhance the effect means the interaction is complex and requires more study before any treatment recommendations.
The abstract notes that the marijuana extract was not fully phytochemically characterized, meaning other compounds may have contributed. The mechanistic analyses were correlational, so cause and effect cannot be established. The study was in rats, not humans, and used a specific model of Alzheimer's-like pathology. Co-administration with estradiol did not show synergy, but the reasons are unclear. Further studies are needed to clarify mechanisms and translational relevance.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Modulation of spatial learning and memory by cannabinoid-estrogen interaction in an AD-like cognitive impairment: The role of cannabinoid receptors and BDNF protein — Mohammad Ali Mirshekar, Farzaneh Nadi, Hamed Fanaei et al. — IBRO neuroscience reports — doi:10.1016/j.ibneur.2026.09.002
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.